Tevogen Bio will provide the primary staff and operations for the facility, which is a key component of the company’s long-term strategy ... These statements are based on management’s expectations, ...

The company has a strong cash position of $471m, despite a net loss of $63m in 2024, providing a long funding runway. Click ...

WARREN, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq ... These statements are based on management's expectations, assumptions, estimates, ...

Key Insights Given the large stake in the stock by institutions, Zura Bio's stock price might be vulnerable to ...

Moderated discussion with Stephen Strickland, MD, MSCI, internationally respected leukemia researcher, Director of Leukemia Research for Sarah Cannon Research Institute and Kanya Rajangam, MD, PhD, ...

The agreement would facilitate providing Tevogen Bio with in-house cell therapy production capabilitiesFormalized agreement aligns with previously announced topline forecasts WARREN, N.J., April 17 ...

Live moderated webcast with members of the Senti Bio management team on Wednesday, April 23rd at 4:00 PM ET SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc.

However, the new management have apparently ... I would concur there is a risk that a larger study will uncover more safety issues, and the company also warns that wide-scale study withdrawals ...

This announcement marks the third foundational support pillar for Tevogen.AI, the Company’s AI initiative which aims to transform precision medicine: Microsoft Research – contributing digital ...

During the post-covid bull-run, as investors chased themes around sustainability, the engineering conglomerate’s stock grew ...